Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06927856 · ClinicalTrials.gov registry record · NA
The Test-to-PrEP Study
A NA study of HIV Infections, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 320
- Enrollment target
- 1
- Study location
NCT06927856: Recruiting NA study of HIV Infections, sponsored by University of Miami.
NCT06927856 is a NA study of HIV Infections that is actively recruiting participants, run by University of Miami. The registered enrollment target is 320 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06927856, a NA study of HIV Infections, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.
Primary Outcome
Number of Alter participants per ego who use an HIV self-test kit, indicated by completion of the Post-Test Survey.
Conditions Studied
Interventions
- BEHAVIORAL Test-to-PrEP
- BEHAVIORAL Access by Referral
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2025-04-10 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
What NCT06927856 shows while recruiting
NCT06927856 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (28% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Test-to-PrEP is the first listed.
NCT06927856 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06927856 about?
NCT06927856 is a clinical study titled "The Test-to-PrEP Study". To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.
What is the current status of trial NCT06927856?
This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2025-04-10. Estimated completion is 2028-07-01.
What conditions does trial NCT06927856 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06927856?
The interventions under investigation include: Test-to-PrEP (BEHAVIORAL), Access by Referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT06927856?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06927856 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06927856's enrollment target sits among peer trials
320 110th of 542 higher than 432 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI